Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Fish and Richardson
Julphar
Daiichi Sankyo
Johnson and Johnson
Baxter
McKinsey
Argus Health
QuintilesIMS
Healthtrust

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019435

« Back to Dashboard

NDA 019435 describes NIX, which is a drug marketed by Glaxosmithkline and Medtech Products and is included in two NDAs. It is available from one supplier. Additional details are available on the NIX profile page.

The generic ingredient in NIX is permethrin. There are five drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the permethrin profile page.
Summary for 019435
Tradename:NIX
Applicant:Glaxosmithkline
Ingredient:permethrin
Patents:0
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019435

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:LOTION;TOPICALStrength1%
Approval Date:Mar 31, 1986TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Farmers Insurance
Medtronic
Baxter
Colorcon
US Department of Justice
Argus Health
Fuji
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot